Juvenile chronic myelogenous leukemia multilineage CD34+ cells: Aberrant growth and differentiation properties

Stem Cells

Volumn 14, Issue 6, 1996, Pages 690-701

  Freedman, Melvin H ^a   Hitzler, Johann K ^b   Bunin, Nancy ^b   Grunberger, Tom ^b   Squire, Jeremy ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

CD34+ cells; Juvenile chronic myelogenous leukemia; Monocyte macrophage colonies

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; STEEL FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL GROWTH; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLONOGENIC ASSAY; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROID CELL; HUMAN; HUMAN CELL; INFANT; MACROPHAGE; MALE; MONOCYTE; PRESCHOOL CHILD; SPLEEN CELL;

EID: 0029808527     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140690     Document Type: Article

References (39)

1. Estrov Z, Zimmerman B, Grunberger T et al. Characterization of malignant peripheral blood cells of juvenile chronic myelogenous leukemia. Cancer Res 1986;46:6456-6461.
2. Estrov Z, Grunberger T, Chan HSL et al. Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures. Blood 1986;67:1382-1387.
3. Estrov Z, Dube IA, Chan HSL et al. Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission. Blood 1987;70:1466-1469.
4. Estrov Z, Lau AS, Williams BRG et al. Recombinant human interferon alpha-2 and juvenile chronic myelogenous leukemia: cell receptor binding, enzymatic induction, and growth suppression in vitro. Exp Hematol 1987;15:127-132.
5. Freedman MH, Estrov Z. Juvenile chronic myelogenous leukemia and histiocytosis syndromes in children. Lancet 1987;1:754.
6. Freedman MH, Estrov Z, Chan HSL. Juvenile chronic myelogenous leukemia. Am J Pediatr Hematol Oncol 1988;10:261-267.
7. Chan HSL, Estrov Z, Weitzman SS et al. The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 1987;5:1960-1967.
8. Kirby MA, Weitzman S, Freedman MH. Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection. Am J Pediatr Hematol Oncol 1990;12:292-296.
9. Freedman MH, Cohen A, Grunberger T et al. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia. Br J Haematol 1992;80:40-48.
10. Gualtieri RJ, Emanuel PD, Zuckerman KS et al. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood 1989;74:2360-2367.
11. Emanuel PD, Bates LJ, Castleberry RP et al. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991;77:925-929.
12. Bagby GC, Dinarello CA, Neerhout RC et al. Interleukin-1-dependent paracrine granulopoiesis in chronic granuloycytic leukemia of the juvenile type. J Clin Invest 1988;82:1430-1436.
13. Altman AJ, Schwartz AD. Malignant Diseases of Infancy, Childhood and Adolescence. Philadelphia: W.B. Saunders, 1983:228-229.
14. Nathan DG, Oski FA. Hematology of Infancy and Childhood, 4th Edition. Philadelphia: W.B. Saunders, 1993:1293-1295.
15. Busque L, Gilliland DG, Prychal JT et al. Clonality in juvenile chronic myelogenous leukemia. Blood 1995; 85:21-30.
16. Lau RC, Squire J, Brisson L et al. Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML). Leukemia 1994;8:903-908.
17. Estrov Z, O'Brien PM, Horvath A et al. Interruption of autocrine/paracrine growth factor stimulatory mechanisms: a potential approach for juvenile chronic myelogenous leukemia therapy. Int J Pediatr Hematol Oncol 1994;1:253-258.
18. Berenson RJ, Bensinger WI, Kalamasz D. Positive selection of viable cell populations using avidin-biotin immunoadsorption. J Immunol Methods 1986;91:11-19
19. Berenson RJ, Bensinger WI, Kalamasz D et al. Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoabsorption. Blood 1986;67:509-515.
20. Berenson RJ, Bensinger WI, Kalamasz D et al. Engraftment of dogs with Ia-positive marrow cells isolated by avidin-biotin immunoadsorption. Blood 1987;69:1363-1367.
21. Tucker SB, Pierre RV, Jordan RE. Rapid identification of monocytes in mixed mononuclear cell preparations. J Immunol Methods 1977;14:267-269.
22. Lichter P, Tang CJ, Call K et al. High resolution mapping of human chromosome II by in situ hybridization with cosmid clones. Science 1990;247:64-69.
23. Lau AS, Livesey JF. Endotoxin induction of tumor necrosis factor is enchanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome. J Clin Invest 1989;84:738-743.
24. Mohler KM, Torrance DS, Smith CA et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-1561.
25. Inoue S, Shibata T, Ravindranath Y et al. Clonal origin of erythroid cells in juvenile chronic myelogenous leukemia. Blood 1987;69:975-976.
26. Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986;67:842-845.
27. Brandt JE, Baird N, Lu L et al. Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 1988;82:1017-1027.
28. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony forming cells by expression of the CD33 and CD34 antigen and light scatter properties. J Exp Med 1989;169:1721-1731.
29. Sutherland HJ, Eaves CJ, Eaves AC et al. Characterization and partial purification of human marrow cells capable of initiation long-term hematopoiesis in vitro. Blood 1989;74:1563-1570.
30. Sutherland HJ, Lansdorp PM, Henkelman DH et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive stromal layers. Proc Natl Acad Sci USA 1990;87:3584-3588.
31. + marrow cells engraft lethally irradiated baboons. J Clin Invest 1988;81:951-955.
32. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991;77:1717-1722.
33. + precursor cells. J Exp Med 1991;174:1283-1286.
34. Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992;89:2804-2808.
35. Craig W, Kay R, Cutler RL et al. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993;177:1331-1342.
36. - hematopoietic stem cells. Blood 1994;83:1515-1526.
37. Schiro R, Longoni D, Rossi V et al. Suppression of juvenile myelogenous leukemia colony growth by interleukin-1 receptor antagonist. Blood 1994;83:460-465.
38. Emanuel PD, Bates LJ, Zhu S-W et al. The role of monocyte-derived hematopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Exp Hematol 1991;19:1017-1024.
39. Lapidot T, Grunberger T, Vermoor J et al. Identification of immature juvenile chronic myelogenous leukemia cells capable of initiating the disease in primary and secondary SCID mice. Blood 1996;88:2655-2664.